Literature DB >> 32678972

New psychoactive substances on dark web markets: From deal solicitation to forensic analysis of purchased substances.

Bronislav Jurásek1,2, Ivan Čmelo3, Jan Svoboda4, Jan Čejka5, Daniel Svozil3, Martin Kuchař1,2.   

Abstract

The dark web scene has been drawing the attention of law enforcement agencies and researchers alike. To date, most of the published works on the dark web are based on data gained by passive observation. To gain a more contextualized perspective, a study was conducted in which three vendors were selected on the "Dream Market" dark web marketplace, from whom subsequently several new psychoactive substances (NPS) were ordered. All transactions were documented from the initial drug deal solicitation to the final qualitative analysis of all received samples. From the selected vendors, a total of nine NPS samples was obtained, all of which were analyzed by NMR, HRMS, LC-UV, and two also by x-ray diffraction. According to our analyses, four of the five substances offered under already known NPS names contained a different NPS. The selected vendors therefore either did not know about their product, or deliberately deceived the buyers. Furthermore, two of three obtained samples of purportedly novel NPS were identified as already documented substances sold under a different name. However, the third characterized substance sold as "MPF-47700" was a novel, yet uncharacterized, NPS. Finally, we received a single undeclared substance, later identified as 5F-ADB. In addition to chemical analysis of the nine obtained NPS samples, the methodology used also yielded contextual information about the accessibility of NPS on the dark web, the associated purchase process, and the modus operandi of three NPS vendors. Direct participation in dark web marketplaces seems to provide additional layers of information useful for forensic studies.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Dream Market; MPF-47700; dark web; darknet; new psychoactive substances

Year:  2020        PMID: 32678972     DOI: 10.1002/dta.2901

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  3 in total

1.  New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?

Authors:  Simona Napoletano; Giuseppe Basile; Alfredo Fabrizio Lo Faro; Francesca Negro
Journal:  Acta Biomed       Date:  2022-05-11

2.  New Psychoactive Substances and evolving criminal dynamics against the backdrop of the fourth industrial revolution.

Authors:  Simona Zaami
Journal:  Acta Biomed       Date:  2022-05-11

3.  Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances.

Authors:  Annagiulia Di Trana; Jeremy Carlier; Paolo Berretta; Simona Zaami; Giovanna Ricci
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.